Eli Lilly And Company

This early-stage study tested a new medicine called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The goal was to check safety and how the body processes the drug. The study was stopped early, so results are limited.

This study aimed to see if the drug baricitinib is safe and works well for children aged 1 to 18 hospitalized with COVID-19. It planned to check how the drug moves through the body and if it reduces the need for breathing support. However, the study was stopped early after enroll…

This study tested an investigational drug called LY3540378 in 332 adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly (HFpEF). The goal was to see if the drug could improve heart function and safety compared to a placebo. The trial…

This early-stage study tested a new drug, LY3127804, alone or with another drug (ramucirumab) in 62 people with advanced solid tumors. The goal was to check safety and find the right dose, but the study was stopped early. No serious side effects were seen, so the best dose could …

This early-phase study tested the safety of a new drug, LY3872386, in healthy volunteers and people with atopic dermatitis (eczema). The trial was stopped early, so no meaningful results were obtained. Only 18 participants were planned, and the study focused on side effects and h…

This study aimed to test the safety of a new drug called LY3405105 in 54 people with advanced solid tumors that had spread. The trial was stopped early, so results are limited. Participants took the drug by mouth and were monitored for side effects and tumor response.

This study tested an experimental drug called LY3454738 in adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it could reduce skin redness, itching, and rash by at least 75% after 16 weeks. The trial was terminated early, so results are limited. Par…

This study tested a medicine called peresolimab in adults with moderate-to-severe rheumatoid arthritis, a condition causing painful, swollen joints. The goal was to see if the drug could reduce symptoms like joint pain and swelling better than a placebo. The trial was stopped ear…

This study aimed to see if lasmiditan, a migraine medicine, is safe and works for children aged 6 to 17. It planned to treat migraine attacks and measure pain relief. The trial was stopped early, so final results are limited, but it may still provide useful information about trea…

This study tested the safety and effectiveness of lasmiditan, a migraine medication, in children aged 6 to 17. Over 12 months, researchers tracked side effects and how well the drug relieved migraine pain within 2 hours. The trial was stopped early, but the results help understan…

This early-stage study tested the safety and side effects of an experimental drug called LY3463251 in healthy and overweight adults. Participants received either the drug or a placebo as a single or multiple injection under the skin. The study was stopped early, and it was not de…

This study tested the safety and side effects of an experimental drug called LY3526318 in 76 healthy adults. Participants took the drug by mouth in either a single dose or multiple doses over several days. The goal was to see how the body processes the drug and whether it causes …